Cargando…
Erratum to: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
Autores principales: | Mancini, Ozge Kizilay, Shum-Tim, Dominique, Stochaj, Ursula, Correa, José A., Colmegna, Inés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309979/ https://www.ncbi.nlm.nih.gov/pubmed/28196520 http://dx.doi.org/10.1186/s13287-017-0504-7 |
Ejemplares similares
-
Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Kizilay Mancini, Ozge, et al.
Publicado: (2015) -
A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
por: Kizilay Mancini, Özge, et al.
Publicado: (2017) -
MSC - targets for atherosclerosis therapy
por: Colmegna, Ines, et al.
Publicado: (2018) -
CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells
por: Psaroudis, Rose Triantafillia, et al.
Publicado: (2022) -
Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo
por: Cheng, Anastasia, et al.
Publicado: (2020)